Page values for "Pembrolizumab"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 864,519 |
| _pageName | Page | Pembrolizumab |
| _pageTitle | String | Pembrolizumab |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Pembrolizumab |
| Short_definition | String | Pembrolizumab - (pronounced) (pem-broh-LIH-zoo-mab) drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that express the protein PD-L1, that have certain mutations (changes) in genes involved in |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |